poractant alfa
Discover more about CUROSURF (proactant alfa), a natural surfactant, and its use in the treatment of respiratory distress syndrome (RDS) or hyaline membrane disease in newborn babies.
CUROSURF is indicated for:1
- The treatment, including early rescue, of RDS or hyaline membrane disease in neonates
- Prophylactic use in premature infants requiring intubation for stabilisation at risk from RDS or with evidence of surfactant deficiency